Abstract:BACKGROUND:Diabetes mellitus is characterized by loss or dysfunction of insulin-producing β-cells in the pancreas, resulting in failure of blood glucose regulation and devastating secondary complications. Thus, β-cells are currently the prime target for cell-replacement and regenerative therapy. Triggering endogenous repair is a promising strategy to restore β-cell mass and normoglycemia in diabetic patients. Potential strategies include targeting specific β-cell subpopulations to increase proliferation or maturation. Alternatively, transdifferentiation of pancreatic islet cells (e.g. α- or δ-cells), extra-islet cells (acinar and ductal cells), hepatocytes, or intestinal cells into insulin-producing cells might improve glycemic control. To this end, it is crucial to systematically characterize and unravel the transcriptional program of all pancreatic cell types at the molecular level in homeostasis and disease. Furthermore, it is necessary to better determine the underlying mechanisms of β-cell maturation, maintenance, and dysfunction in diabetes, to identify and molecularly profile endocrine subpopulations with regenerative potential, and to translate the findings from mice to man. Recent approaches in single-cell biology started to illuminate heterogeneity and plasticity in the pancreas that might be targeted for β-cell regeneration in diabetic patients.SCOPE OF REVIEW:This review discusses recent literature on single-cell analysis including single-cell RNA sequencing, single-cell mass cytometry, and flow cytometry of pancreatic cell types in the context of mechanisms of endogenous β-cell regeneration. We discuss new findings on the regulation of postnatal β-cell proliferation and maturation. We highlight how single-cell analysis recapitulates described principles of functional β-cell heterogeneity in animal models and adds new knowledge on the extent of β-cell heterogeneity in humans as well as its role in homeostasis and disease. Furthermore, we summarize the findings on cell subpopulations with regenerative potential that might enable the formation of new β-cells in diseased state. Finally, we review new data on the transcriptional program and function of rare pancreatic cell types and their implication in diabetes.MAJOR CONCLUSION:Novel, single-cell technologies offer high molecular resolution of cellular heterogeneity within the pancreas and provide information on processes and factors that govern β-cell homeostasis, proliferation, and maturation. Eventually, these technologies might lead to the characterization of cells with regenerative potential and unravel disease-associated changes in gene expression to identify cellular and molecular targets for therapy.

Modelling human diabetes ex vivo: a glance at maturity onset diabetes of the young

From glucose sensing to exocytosis: takes from maturity onset diabetes of the young

Systematic Single-Cell Analysis Provides New Insights into Heterogeneity and Plasticity of the Pancreas.

Towards a better understanding of diabetes mellitus using organoid models

Experimental Models Of Transcription Factor-Associated Maturity-Onset Diabetes Of The Young

Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Matching model with mechanism: Appropriate rodent models for studying various aspects of diabetes pathophysiology

Investigating the pathogenicity of the recessive HNF1A p.A251T variant in monogenic diabetes using iPSC-derived beta-like cells

Understanding Type 1 Diabetes: Etiology and Models

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

The Anna Karenina Model of β-Cell Maturation in Development and Their Dedifferentiation in Type 1 and Type 2 Diabetes

Heterogeneity and altered β-cell identity in the TallyHo model of early-onset type 2 diabetes

An Overview Of Valuable Scientific Models For Diabetes Mellitus

Progress in experimental models to investigate the in vivo and in vitro antidiabetic activity of drugs

In vivo models of gestational and type 2 diabetes mellitus characterized by endocrine pancreas cell impairment

Modeling and Phenotyping Acute and Chronic Type 2 Diabetes Mellitus In Vitro in Rodent Heart and Skeletal Muscle Cells

Genetics of type 2 diabetes: insight from targeted mouse mutants

Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility

Age-Dependent Pancreatic Gene Regulation Reveals Mechanisms Governing Human Β Cell Function.

Experimental animal models for diabetes and its related complications—a review